RNA-Targeted Antiviral Drug Discovery Scientist

Times Higher Education; Hong Kong; Vor Ort; HKD 480.000 - 720.000; Vollzeit

Benefits dieser Stelle

Housing benefits

Annual leave

Medical benefits

University contribution to retirement

Zusammenfassung

THE UNIVERSITY OF HONG KONG in Hong Kong invites applications for the role of Assistant Research Officer/Research Officer in the Department of Microbiology, School of Clinical Medicine, to commence as soon as possible on a one-year temporary basis or a two-year fixed-term basis, with the possibility of renewal subject to funding and performance.

The appointee will join an antiviral drug discovery project focused on developing small-molecule approaches to target conserved viral RNA elements, with

Qualifikationen

• Ph.D. degree and at least 3 years of postdoctoral research on related projects.
• Prior experience in virology is preferred and advantageous.
• Excellent communication and interpersonal skills for multidisciplinary teams.
• Ability to work independently and in collaborative settings.

Aufgaben

• Contribute to viral RNA target analysis, RNA structure modeling, virtual screening, compound prioritization, and small-molecule design.
• Lead and execute end-to-end research projects in RNA-targeted therapeutics and antiviral drug discovery.
• Design translational research strategies and perform biostatistical analysis of experimental data.
• Collaborate with colleagues, share knowledge proactively, and deliver high-quality results in a fast-paced environment.

Kenntnisse

Excellent communication

Interdisciplinary collaboration

Virology experience

RNA structural biology

Computational drug screening

Molecular docking

Ausbildung

Ph.D. degree

Jobbeschreibung

THE UNIVERSITY OF HONG KONG in Hong Kong invites applications for the role of Assistant Research Officer/Research Officer in the Department of Microbiology, School of Clinical Medicine, to commence as soon as possible on a one-year temporary basis or a two-year fixed-term basis, with the possibility of renewal subject to funding and performance.

The appointee will join an antiviral drug discovery project focused on developing small-molecule approaches to target conserved viral RNA elements, with